Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
146241
ACE effectors in the heart and lung tissues.
Published 2017“…<p>Conformational fingerprinting of heart and lung ACEs was performed with a set of 17 mAbs to ACE as in the legend to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0181976#pone.0181976.g003" target="_blank">Fig 3</a>. …”
-
146242
Progressive differences between IPCs and OC surface proportions promoted 2° and 3° formation.
Published 2010“…‘No OC Expansion’, No Death' curve indicates constant OC surface area (no expansion) and no cell death. (<b>C</b>) A graph indicating the decrease in cell number for the different simulations. …”
-
146243
LZAP regulates p38 phosphorylation.
Published 2011“…Levels of p38 and LZAP in p38 immunoprecipitates were determined by immunoblotting with antibodies recognizing p38 or LZAP as described <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0016427#pone.0016427-Wang1" target="_blank">[2]</a>). …”
-
146244
Increased CPEB4 protein level in most HCC specimens.
Published 2016“…<p>Western blot analysis of CPEB4 MoAb (homemade#2) described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155025#pone.0155025.g004" target="_blank">Fig 4A</a> in tumorous (T) and adjacent non-tumorous (N) liver samples from 49 HCC patients at different stages (S1-S4). …”
-
146245
Figure 3 from Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers
Published 2024“…JHU083 treatment decreases tumor growth in MB49-RFP<sup>+</sup> tumors relative to nontreated (<i>n</i> = 5 or 6/group) tumors. …”
-
146246
-
146247
-
146248
-
146249
-
146250
-
146251
-
146252
-
146253
-
146254
-
146255
-
146256
-
146257
-
146258
-
146259
-
146260